Federal Supply Schedule 36F79720D0225
Award Date 9/15/20
Last Date to Order 9/14/26
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Federal Supply Schedule (FSS) contract award is for Drugs, Pharmaceuticals, & Hematology Related Products (65 I B). The prime contractor is Orchard Therapeutics North America, a for-profit foreign-owned organization. The contract has a ceiling value of $225,000.00 and a period of performance from February 15, 2025 to February 14, 2030. The contract is awarded by the Veterans Integrated Service Network 12, a civilian federal agency. The purpose of the contract is to provide the agency...
- This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to EMD Serono Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $271,515,660.00. The period of performance runs from the award date of April 15, 2018 through April 14, 2025. The contract is intended to procure a wide range of pharmaceutical and hematology-related products for the Department of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
- The contract is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Eyevance Pharmaceuticals LLC, a foreign-owned for-profit manufacturer. The FSS contract is under Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, with a potential value of $450,000 and a period of performance through December 14, 2024. The contract aims to procure a range of pharmaceutical and drug products from the vendor. As an FSS...
- This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
- The Federal Supply Schedule (FSS) contract award to Mylan Pharmaceuticals Inc. is for a five-year period, from January 1, 2023 to December 31, 2027, with a total ceiling value of $364,546,690.00. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the Department of Veterans Affairs (VA), to provide a full range of drugs and hematology-related products. As the prime contractor, Mylan Pharmaceuticals will supply prescription medications and...
- The provided information details a Federal Supply Schedule (FSS) contract award to Aveo Pharmaceuticals, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The $45,580,967.00 ceiling value contract has an ultimate completion date of October 14, 2026. The contract aims to procure pharmaceutical and hematology-related products to support the VA's healthcare operations. As an FSS contract, it allows for the placement of task...
- The Federal Supply Schedule (FSS) contract awarded to Exela Pharma Sciences, LLC by the U.S. Department of Veterans Affairs (VA) for Veterans Integrated Service Network 12 has a total ceiling value of $20,304,570.00 and a period of performance from September 29, 2024, to September 30, 2029. This multiple-award contract allows the VA to efficiently procure a wide range of drugs, pharmaceuticals, and hematology-related products from Exela Pharma Sciences to support the healthcare operations and...
- The Federal Supply Schedule contract is a multiple award vehicle awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to Validus Pharmaceuticals, LLC. The contract has a period of performance from April 1, 2023 to March 31, 2028 and a ceiling value of $2,420,310.00. The contract is for pharmaceutical and drug products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The agency aims to procure a wide range of pharmaceutical and...
- This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Methapharm Inc., a foreign-owned, for-profit organization. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) FSS contract. The contract has a ceiling value of $811,760.00 and a period of performance through December 31, 2027. As an FSS contract, it is a multiple-award vehicle, meaning it can be used by...